Li C Xia
Overview
Explore the profile of Li C Xia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bai X, Duren Z, Wan L, Xia L
NAR Genom Bioinform
. 2024 Mar;
6(1):lqae017.
PMID: 38486887
Latest advancements in the high-throughput single-cell genome (scDNA) and transcriptome (scRNA) sequencing technologies enabled cell-resolved investigation of tissue clones. However, it remains challenging to cluster and couple single cells for...
2.
Ou L, Zhao X, Wu I, Yu Z, Xiong Z, Xia L, et al.
Int J Biol Macromol
. 2024 Feb;
262(Pt 2):130131.
PMID: 38354937
Deleted in breast cancer 1 (DBC1) is a human nuclear protein that modulates the activities of various proteins involved in cell survival and cancer progression. Oxidized form of nicotinamide adenine...
3.
Feng C, Fang H, Wang F, Chen W, Xia L, Lan D, et al.
J Agric Food Chem
. 2023 Oct;
71(43):16352-16361.
PMID: 37800479
Nonspecific phospholipase C (NPC) plays a pivotal role in hydrolyzing phospholipids, releasing diacylglycerol─an essential second messenger. Extensive research has elucidated the structure and function of bacterial and plant NPCs, but...
4.
Ai D, Zhang X, Zhang Q, Li X, Wang Y, Liu X, et al.
Comput Biol Med
. 2023 Mar;
157:106774.
PMID: 36931204
Studies have found that different immune subtypes are present in the same tumor. Different tumor subtypes have different tumor microenvironments (TME). This means that the efficacy of immunotherapy in actual...
5.
Ai D, Wang M, Zhang Q, Cheng L, Wang Y, Liu X, et al.
Front Genet
. 2023 Mar;
14:1148470.
PMID: 36911403
Colon adenocarcinoma is the most common type of colorectal cancer. The prognosis of advanced colorectal cancer patients who received treatment is still very poor. Therefore, identifying new biomarkers for prognosis...
6.
Sun T, Zhao L, Van Hummelen P, Martin B, Hornbacker K, Lee H, et al.
Endocr Relat Cancer
. 2022 Sep;
29(12):665-679.
PMID: 36165930
High-grade (grade 3) neuroendocrine neoplasms (G3 NENs) have poor survival outcomes. From a clinical standpoint, G3 NENs are usually grouped regardless of primary site and treated similarly. Little is known...
7.
Ai D, Xing Y, Zhang Q, Wang Y, Liu X, Liu G, et al.
Front Immunol
. 2022 May;
13:853213.
PMID: 35493464
Recent transcriptomics and metagenomics studies showed that tissue-infiltrating immune cells and bacteria interact with cancer cells to shape oncogenesis. This interaction and its effects remain to be elucidated. However, it...
8.
Loke J, Alim I, Yam S, Klugman S, Xia L, Gruber D, et al.
HGG Adv
. 2022 Feb;
3(2):100085.
PMID: 35146455
Identifying women at high risk for developing breast cancer is potentially lifesaving. Patients with pathogenic genetic variants can embark on a program of surveillance for early detection, chemoprevention, and/or prophylactic...
9.
Chilunda V, Martinez-Aguado P, Xia L, Cheney L, Murphy A, Veksler V, et al.
Front Immunol
. 2021 Jun;
12:665773.
PMID: 34108966
The COVID-19 pandemic has caused more than three million deaths globally. The severity of the disease is characterized, in part, by a dysregulated immune response. CD16+ monocytes are innate immune...
10.
Xia L, Van Hummelen P, Kubit M, Lee H, Bell J, Grimes S, et al.
Sci Rep
. 2020 Mar;
10(1):5009.
PMID: 32193467
DNA copy number aberrations (CNA) are frequently observed in colorectal cancers (CRC). There is an urgent need for CNA-based biomarkers in clinics,. n For Stage III CRC, if combined with...